Related Experiment Video
Updated: Jan 19, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses
S Bao1, R S Tibbetts, K M Brumbaugh
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Genotoxic stress triggers the activation of checkpoints that delay cell-cycle progression to allow for DNA repair. Studies in fission yeast implicate members of the Rad family of checkpoint proteins, which includes Rad17, Rad1, Rad9 and Hus1, as key early-response elements during the activation of both the DNA damage and replication checkpoints. Here we demonstrate a direct regulatory linkage between the human Rad17 homologue (hRad17) and the checkpoint kinases, ATM and ATR. Treatment of human cells with genotoxic agents induced ATM/ATR-dependent phosphorylation of hRad17 at Ser 635 and Ser 645. Overexpression of a hRad17 mutant (hRad17AA) bearing Ala substitutions at both phosphorylation sites abrogated the DNA-damage-induced G2 checkpoint, and sensitized human fibroblasts to genotoxic stress. In contrast to wild-type hRad17, the hRad17AA mutant showed no ionizing-radiation-inducible association with hRad1, a component of the hRad1-hRad9-hHus1 checkpoint complex. These findings demonstrate that ATR/ATM-dependent phosphorylation of hRad17 is a critical early event during checkpoint signalling in DNA-damaged cells.
Insights
Genotoxic stress activates cell cycle checkpoints for DNA repair. Human Rad17 (hRad17) phosphorylation by ATM/ATR kinases is crucial for this DNA damage response, regulating cell cycle arrest and DNA repair signaling.
Area of Science:
- Cellular biology
- Molecular genetics
- Biochemistry
Background:
- Genotoxic stress activates cell cycle checkpoints to facilitate DNA repair.
- The Rad family of checkpoint proteins, including Rad17, Rad1, Rad9, and Hus1, are critical for DNA damage and replication checkpoint activation in fission yeast.
- The precise role of human Rad17 (hRad17) in DNA damage response pathways requires further elucidation.
Purpose of the Study:
- To investigate the regulatory linkage between human Rad17 (hRad17) and the ATM and ATR checkpoint kinases.
- To determine the functional significance of hRad17 phosphorylation at specific sites in response to genotoxic stress.
- To elucidate the role of hRad17 in the DNA-damage-induced G2 checkpoint and its association with checkpoint protein complexes.
Main Methods:
- Treatment of human cells with genotoxic agents.
- Analysis of hRad17 phosphorylation at Ser 635 and Ser 645 by ATM/ATR kinases.
- Overexpression of wild-type hRad17 and a phosphorylation-deficient mutant (hRad17AA).
- Assessment of G2 checkpoint abrogation and cellular sensitivity to genotoxic stress.
- Investigation of hRad17 association with hRad1 using co-immunoprecipitation assays.
Main Results:
- Genotoxic agents induced ATM/ATR-dependent phosphorylation of hRad17 at Ser 635 and Ser 645 in human cells.
- Overexpression of the hRad17AA mutant abrogated the DNA-damage-induced G2 checkpoint.
- The hRad17AA mutant sensitized human fibroblasts to genotoxic stress.
- The hRad17AA mutant failed to associate with hRad1 following ionizing radiation, unlike wild-type hRad17.
Conclusions:
- ATM/ATR-dependent phosphorylation of hRad17 at Ser 635 and Ser 645 is a critical early event in DNA damage checkpoint signaling.
- This phosphorylation event is essential for the proper activation of the G2 checkpoint and cellular resistance to genotoxic stress.
- hRad17 phosphorylation regulates its interaction with the hRad1-hRad9-hHus1 checkpoint complex, highlighting its central role in DNA repair pathways.
Related Concept Videos
Heart Failure V: Medical Management
Myocarditis III: Medical Management
Endocarditis III: Medical Management
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Inhaled Medications
Preparing and Administering Inhaled Medications
Inhaled medications are prescribed for conditions affecting the bronchi, which branch off of the trachea, and bronchioles, which are progressively smaller conducting airways spread throughout the lung tissue. These conditions can be classified as acute (i.e., temporary, with quick onset) or chronic (i.e., persistent and/or recurrent symptoms lasting months to years). Common acute conditions...